by Thanos Panagiotidis | Mar 27, 2015 | Drug Discovery Applications, Publications and presentations
Analyzing Selectivity Through Multi-dimensional Activity Cliff Analysis Dr Tim Cheeseright, Cresset, gave this presentation at the “Guiding Optimal Compound Design and Development Symposium” held in Cambridge, MA, USA on 19 March 2015. AbstractDuring lead... by Thanos Panagiotidis | Mar 27, 2015 | Drug Discovery Applications, Publications and presentations
Understanding Compound Quality Dr Paul Leeson, Paul Leeson Consulting Ltd, gave this presentation at the “Guiding Optimal Compound Design and Development Symposium” held in Cambridge, MA, USA on 19 March 2015. AbstractA significant body of data suggests... by Thanos Panagiotidis | Mar 27, 2015 | Drug Discovery Applications, Publications and presentations
Predicting Adverse Drug Reactions: What Works and What Doesn’t Dr Nigel Green, Pfizer, gave this presentation at the “Guiding Optimal Compound Design and Development Symposium” held in Cambridge, MA, USA on 19 March 2015. AbstractThe ability to predict the... by Thanos Panagiotidis | Mar 27, 2015 | In Silico Modelling, Publications and presentations
Modeling of Chemical and Physical Stability of Pharmaceuticals Dr Yuriy Abramov, Pfizer, gave this presentation at the “Guiding Optimal Compound Design and Development Symposium” held in Cambridge, MA, USA on 19 March 2015. AbstractOne of the major... by Thanos Panagiotidis | Mar 27, 2015 | In Silico Modelling, Publications and presentations
Predicting Metabolites – Enhancing an Expert System with Machine Learning Dr Christopher Barber, Lhasa Limited, gave this presentation at the “Guiding Optimal Compound Design and Development Symposium” held in Cambridge, MA, USA on 19 March 2015....
Recent Comments